Contribution of residues A54 and L55 of the human insulin-like growth factor-II (IGF-II) A domain to Type 2 IGF receptor binding specificity
dc.contributor.author | Forbes, B. | |
dc.contributor.author | McNeil, K. | |
dc.contributor.author | Scott, C. | |
dc.contributor.author | Surinya, K. | |
dc.contributor.author | Cosgrove, L. | |
dc.contributor.author | Wallace, J. | |
dc.date.issued | 2001 | |
dc.description.abstract | The underlying specificity of the interaction between insulin-like growth factor-II (IGF-II) and mammalian Type 2 insulin-like growth factor/cation-independent mannose 6 phosphate receptor (IGF2R) is not understood. We have mutated residues A54 and L55 of IGF-II in the second A domain helix to arginine (found in the corresponding positions of IGF-I) and measured IGF2R binding. There is a 4- and 3.3-fold difference in dissociation constants for A54R IGF-II and L55R IGF-II, respectively, and a 6.6-fold difference for A54R L55R IGF-II compared with IGF-II as measured by BlAcore analysis using purified rat IGF2R. This is also confirmed using cross-linking and soluble rat placental membrane receptor binding assays. Binding to the type I IGF receptor (IGF1R) and IGF binding protein-2 (IGFBP-2) is not altered. We can, therefore, conclude that residues at positions 54 and 55 in IGF-II are important for and equally contribute to IGF2R binding. | |
dc.identifier.citation | Growth Factors, 2001; 19(3):163-173 | |
dc.identifier.doi | 10.3109/08977190109001084 | |
dc.identifier.issn | 0897-7194 | |
dc.identifier.issn | 1029-2292 | |
dc.identifier.uri | http://hdl.handle.net/2440/28113 | |
dc.language.iso | en | |
dc.publisher | Harwood Acad Publ GMBH | |
dc.source.uri | https://doi.org/10.3109/08977190109001084 | |
dc.subject | Cell Membrane | |
dc.subject | Placenta | |
dc.subject | Animals | |
dc.subject | Humans | |
dc.subject | Rats | |
dc.subject | Cations | |
dc.subject | Receptor, IGF Type 1 | |
dc.subject | Peptides | |
dc.subject | Insulin-Like Growth Factor II | |
dc.subject | Proteins | |
dc.subject | Receptor, IGF Type 2 | |
dc.subject | Recombinant Proteins | |
dc.subject | Cross-Linking Reagents | |
dc.subject | Ligands | |
dc.subject | Protein Structure, Tertiary | |
dc.subject | Protein Binding | |
dc.subject | Protein Folding | |
dc.subject | Dose-Response Relationship, Drug | |
dc.subject | Kinetics | |
dc.subject | Mutation | |
dc.subject | Plasmids | |
dc.subject | Models, Molecular | |
dc.subject | Time Factors | |
dc.title | Contribution of residues A54 and L55 of the human insulin-like growth factor-II (IGF-II) A domain to Type 2 IGF receptor binding specificity | |
dc.type | Journal article | |
pubs.publication-status | Published |